From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery

被引：795

作者：

Banks, William A. ^{[1
,2
]}

机构：

[1] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA

[2] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, 1660 S Columbian Way, Seattle, WA 98108 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 04期

关键词：

AMYLOID-BETA-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; RECEPTOR-RELATED PROTEIN-1; MOUSE CEREBRAL PERICYTES; NECROSIS-FACTOR-ALPHA; SPINAL-CORD BARRIER; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ENDOTHELIAL-CELLS; P-GLYCOPROTEIN;

D O I：

10.1038/nrd.2015.21

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

One of the biggest challenges in the development of therapeutics for central nervous system (CNS) disorders is achieving sufficient blood-brain barrier (BBB) penetration. Research in the past few decades has revealed that the BBB is not only a substantial barrier for drug delivery to the CNS but also a complex, dynamic interface that adapts to the needs of the CNS, responds to physiological changes, and is affected by and can even promote disease. This complexity confounds simple strategies for drug delivery to the CNS, but provides a wealth of opportunities and approaches for drug development. Here, I review some of the most important areas that have recently redefined the BBB and discuss how they can be applied to the development of CNS therapeutics.

引用

页码：275 / +

页数：18

共 175 条

[1] Astrocyte-endothelial interactions at the blood-brain barrier [J].

Abbott, NJ ;

Rönnbäck, L ;

Hansson, E .

NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53

[2] BLOOD-BRAIN-BARRIER IN ALZHEIMER DEMENTIA AND IN NONDEMENTED ELDERLY - AN IMMUNOCYTOCHEMICAL STUDY [J].

ALAFUZOFF, I ;

ADOLFSSON, R ;

GRUNDKEIQBAL, I ;

WINBLAD, B .

ACTA NEUROPATHOLOGICA, 1987, 73 (02) :160-166

[3] A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo [J].

Atwal, Jasvinder K. ;

Chen, Yongmei ;

Chiu, Cecilia ;

Mortensen, Deborah L. ;

Meilandt, William J. ;

Liu, Yichin ;

Heise, Christopher E. ;

Hoyte, Kwame ;

Luk, Wilman ;

Lu, Yanmei ;

Peng, Kun ;

Wu, Ping ;

Rouge, Lionel ;

Zhang, Yingnan ;

Lazarus, Robert A. ;

Scearce-Levie, Kimberly ;

Wang, Weiru ;

Wu, Yan ;

Tessier-Lavigne, Marc ;

Watts, Ryan J. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (84)

[4] Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia [J].

Avison, MJ ;

Nath, A ;

Greene-Avison, R ;

Schmitt, FA ;

Bales, RA ;

Ethisham, A ;

Greenberg, RN ;

Berger, JR .

JOURNAL OF NEUROVIROLOGY, 2004, 10 (04) :223-232

[5] The blood-brain barrier in neuroimmunology: Tales of separation and assimilation [J].

Banks, W. A. .

BRAIN BEHAVIOR AND IMMUNITY, 2015, 44 :1-8

[6] Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations [J].

Banks, WA .

CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (10) :801-809

[7] Are the extracelluar pathways a conduit for the delivery of therapeutics to the brain? [J].

Banks, WA .

CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (12) :1365-1370

[8] Impaired transport of leptin across the blood-brain barrier in obesity [J].

Banks, WA ;

DiPalma, CR ;

Farrell, CL .

PEPTIDES, 1999, 20 (11) :1341-1345

[9] Triglycerides induce leptin resistance at the blood-brain barrier [J].

Banks, WA ;

Coon, AB ;

Robinson, SM ;

Moinuddin, A ;

Shultz, JM ;

Nakaoke, R ;

Morley, JE .

DIABETES, 2004, 53 (05) :1253-1260

[10]

Banks WA, 2001, J PHARMACOL EXP THER, V297, P1113

← 1 2 3 4 5 6 7 8 9 10 →